Several studies have reported the significant influence of high or increased expression of the galectin-1 protein on different human cancers, including breast cancer [39], head and neck cancer [40], renal cell carcinoma or kidney cancer [41], lung cancer [42], ovarian cancer [43], thyroid carcinoma [44, 45], uterine adenocarcinoma [46], prostate cancer [47] and pancreatic cancer [48]. The gene discussed is LGALS1; the disease is cancer.